SANA BIOTECHNOLOGY INC (SANA)

US7995661045 - Common Stock

4.3  +2.65 (+160.61%)

After market: 4.41 +0.11 (+2.56%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
312.48M293.14M272.56M356.91M285.65M
Research and Development
233.53M268.82M285.89M248.63M257.88M
Selling, General, and Administrative Expenses
67.55M73.30M71.56M50.41M27.77M
Operating Income
-312.48M-293.14M-272.56M-356.91M-285.65M
Interest Income/Expense
11.54M9.94M3.76M680.00K750.00K
Other Income/Expense
128.00K-52.00K-670.00K310.00K100.00K
Non Recurring Items
N/AN/AN/AN/A-500.00K
Income Before Taxes
-305.81M-283.25M-269.48M-355.93M-285.31M
Income Tax
N/AN/AN/A0.000.00
Net Income
-305.81M-283.25M-269.48M-355.93M-285.31M
EBITDA
-289.51M-268.58M-256.93M-345.84M-279.73M
 
Per Share Data
EPS Diluted Total Ops
-1.41-1.46-1.43-2.14-1.55
Non GAAP EPS
-1.36-1.41-1.69-1.83N/A
 
Statistics

All data in USD

Charts